SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001493152-24-007593
Filing Date
2024-02-22
Accepted
2024-02-22 20:13:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13d.htm SC 13D 68607
  Complete submission text file 0001493152-24-007593.txt   70085
Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Subject) CIK: 0001860871 (see all company filings)

IRS No.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-93039 | Film No.: 24666932
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O TEVOGEN BIO HOLDINGS INC. 15 INDEPENDENCE BOULEVARD WARREN NJ 07059
Business Address
Desai Kirti (Filed by) CIK: 0002011765 (see all company filings)

Type: SC 13D